Multiple Myeloma Clinical Trials

Ongoing Multiple Myeloma Trials @ NCIS - Patient Recruitment

 

Setting Treatment Eligibility Status Principal Investigator
Newly Diagnosed

 

MLN9708 versus Placebo for maintenance after transplant in newly diagnosed myeloma Newly diagnosed transplant eligible patients Ongoing Prof Chng Wee Joo
Carfilzomib induction for high-risk myeloma Newly diagnosed transplant eligible patients Ongoing Prof Chng Wee Joo
MLN9708 versus Placebo for maintenance in newly diagnosed myeloma Newly diagnosed transplant ineligible patients Ongoing Prof Chng Wee Joo
Relapse Pomalidomide + dexamethasone Patients who have undergone prior treatment with bortezomib and lenalidomide, and are refractory to lenalidomide Opening Prof Chng Wee Joo

Updated as of 1 December 2015

 


For more information about ongoing Multiple Myeloma Clinical Trials, kindly contact Ms Adeline Lin at adeline_hf_lin@nuhs.edu.sg